Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4812448A · kind A · utility
Inventor
Key dates
| Filing date | Oct 14, 1986 |
| Grant date | Mar 14, 1989 |
| Priority date | — |
| Expiry date | Oct 14, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel pharmacologic therapy for treatment of idiopathic primary open angle glaucoma, drug-induced glaucoma and elevated intraocular pressure is disclosed. The pharmacologic therapy consists of a novel composition comprised of 17-alpha-methyl-testosterone and a physiologically tolerable carrier. In accordance with a method aspect of this invention, the active ingredient is administered to the eye of a warm blooded animal in such a manner as to maintain physiologic or normal intraocular pressure, or to return elevated intraocular pressure to normal levels. The method aspect of this invention may also be employed to ameliorate drug induced elevated intraocular pressure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.